Revision Eye Care, Llc - Medicare Optometrist in Wisconsin Rapids, WI

Revision Eye Care, Llc is a medicare enrolled "Optometrist" provider in Wisconsin Rapids, Wisconsin. Their current practice location is 3341 8th St S, Wisconsin Rapids, Wisconsin. You can reach out to their office (for appointments etc.) via phone at (715) 423-5353.

Revision Eye Care, Llc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Revision Eye Care, Llc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1427563063.

Contact Information

Revision Eye Care, Llc
3341 8th St S,
Wisconsin Rapids, WI 54494-6566
(715) 423-5353
(715) 423-6525



Healthcare Provider's Profile

Full NameRevision Eye Care, Llc
TypeFacility
SpecialityOptometrist
Location3341 8th St S, Wisconsin Rapids, Wisconsin
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1427563063
  • Provider Enumeration Date: 12/05/2017
  • Last Update Date: 12/20/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 0749549855
  • Enrollment ID: O20180118001181

Medical Identifiers

Medical identifiers for Revision Eye Care, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1427563063NPI-NPPES
100078371MedicaidWI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Revision Eye Care, Llc acts as a billing entity for following providers:
Provider NameMichael J Downs
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1508901067
PECOS PAC ID: 2365575651
Enrollment ID: I20100806000831

News Archive

Aubrey receives FDA clearance to market bioengineered wound dressings in U.S.

Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.

DE-MRI before ablation can stage atrial fibrosis and help predict success treatment

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.

Scientists discover molecular mechanism that could help develop new MS treatments

Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) — a chronic inflammatory disease of the central nervous system.

Discovery of genetic marker linked to the risk of acetaminophen-induced liver injury

Acetaminophen (Tylenol and generics) is one of the most commonly used over-the-counter drugs in the United States. While generally safe, acetaminophen is known to cause severe liver injury if taken in high doses. But likely due to genetics, even the recommended dose can induce serious liver damage in a significant number of people.

Read more Medical News

› Verified 4 days ago

Provider NamePeter Richard Falk
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1619315421
PECOS PAC ID: 5092020032
Enrollment ID: I20150819008391

News Archive

Aubrey receives FDA clearance to market bioengineered wound dressings in U.S.

Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.

DE-MRI before ablation can stage atrial fibrosis and help predict success treatment

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.

Scientists discover molecular mechanism that could help develop new MS treatments

Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) — a chronic inflammatory disease of the central nervous system.

Discovery of genetic marker linked to the risk of acetaminophen-induced liver injury

Acetaminophen (Tylenol and generics) is one of the most commonly used over-the-counter drugs in the United States. While generally safe, acetaminophen is known to cause severe liver injury if taken in high doses. But likely due to genetics, even the recommended dose can induce serious liver damage in a significant number of people.

Read more Medical News

› Verified 4 days ago

Provider NameAnna Nicole Kneiert
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1598445850
PECOS PAC ID: 3173987823
Enrollment ID: I20230913002121

News Archive

Aubrey receives FDA clearance to market bioengineered wound dressings in U.S.

Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.

DE-MRI before ablation can stage atrial fibrosis and help predict success treatment

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.

Scientists discover molecular mechanism that could help develop new MS treatments

Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) — a chronic inflammatory disease of the central nervous system.

Discovery of genetic marker linked to the risk of acetaminophen-induced liver injury

Acetaminophen (Tylenol and generics) is one of the most commonly used over-the-counter drugs in the United States. While generally safe, acetaminophen is known to cause severe liver injury if taken in high doses. But likely due to genetics, even the recommended dose can induce serious liver damage in a significant number of people.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Revision Eye Care, Llc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Revision Eye Care, Llc
3341 8th St S,
Wisconsin Rapids, WI 54494-6566

Ph: (715) 423-5353
Revision Eye Care, Llc
3341 8th St S,
Wisconsin Rapids, WI 54494-6566

Ph: (715) 423-5353

News Archive

Aubrey receives FDA clearance to market bioengineered wound dressings in U.S.

Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.

DE-MRI before ablation can stage atrial fibrosis and help predict success treatment

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.

Scientists discover molecular mechanism that could help develop new MS treatments

Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) — a chronic inflammatory disease of the central nervous system.

Discovery of genetic marker linked to the risk of acetaminophen-induced liver injury

Acetaminophen (Tylenol and generics) is one of the most commonly used over-the-counter drugs in the United States. While generally safe, acetaminophen is known to cause severe liver injury if taken in high doses. But likely due to genetics, even the recommended dose can induce serious liver damage in a significant number of people.

Read more News

› Verified 4 days ago


Optometrist in Wisconsin Rapids, WI

Scott Francis Bruneau, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1100 E Riverview Expy, Wisconsin Rapids, WI 54494
Phone: 715-423-1340    Fax: 715-423-1444
Benjamin Reed Clark, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1220 Parkwood Dr, Wisconsin Rapids, WI 54494
Phone: 715-421-2111    Fax: 715-421-2123
Carol Ann Sheker Main, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1220 Parkwood Dr, Wisconsin Rapids, WI 54494
Phone: 715-421-2111    Fax: 715-421-2123
Becker Vision Center S.c.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 2411 3rd St S, Wisconsin Rapids, WI 54494
Phone: 715-424-3937    Fax: 715-423-3330
Parkwood Eyecare Associates, Llc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1220 Parkwood Dr, Wisconsin Rapids, WI 54494
Phone: 715-421-2111    Fax: 715-421-2123
Dr. Michael Desmond Main, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1220 Parkwood Dr, Wisconsin Rapids, WI 54494
Phone: 715-421-2111    Fax: 715-421-2123
Soren A. Nywall, O.D.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1220 Parkwood Drive, Wisconsin Rapids, WI 54494
Phone: 715-421-2111    Fax: 715-421-2123

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.